Baseline plasma vWF, adjusted for age, sex, and combined with ESC/ERS risk stratification score predicted mortality in patients with PAH with an AUC of 0.94, a sensitivity of 81.25% and specificity of 93.75%. This evidence concerns the gene VWF and pulmonary arterial hypertension.